Read More Pharma Industry News Sun Pharmaceutical’s GL0034 study reveals promising obesity treatment outcomes Sun Pharmaceutical Industries Limited unveiled data from its Phase 1 study of GL0034 (Utreglutide), targeting obesity in adults.… byPallavi MadhirajuJune 24, 2024